top of page

REGULATIONS & GUIDELINES FOR CANADIAN RESEARCHERS

ICH-GCP E6 (R2) 

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) - Good Clinical Practice (GCP) - E6 (R2)

​

As its full name indicates, ICH-GCP E6 (R2) is an internationally accepted set of guidelines. These guidelines were  created to protect the safety of clinical research participants while also ensuring high quality data. It is important for all research personnel to be familiar with these guidelines and to implement them in all aspects of their clinical research work. 

​

You can learn more about the history and importance of ICH-GCP in clinical research here.

​

Health Canada Regulations

The Food and Drugs Act, Part C, Division 5: Drugs for Clinical Trials Involving Human Subjects

 

This section of Canada's Food and Drug Regulations outlines the requirements set out by Health Canada for Canadian researchers that are involved in clinical trials with human subjects. Since Health Canada is the national regulatory body that oversees clinical trial research across the country, it is their expectation that researchers are working under these regulations.

​

Health Canada also provides a Guidance Document (GUI-0100) to assist researchers with the interpretation of the Part C, Division 5 regulations, as well as to apply the guidelines of ICH-GCP E6 (R2).

​

 

Other useful resources provided by Health Canada include:

​

- A pre-inspection package to help you prepare for a regulatory inspection by Health Canada

​

- FAQ page for Clinical Trials

​

- Guide 0043 - Classification of observations made in the conduct of inspections of clinical trials

​

​

Privacy Legislation

Canada's federal government has put in place ​The Personal Information Protection and Electronic Documents Act (PIPEDA) which lays out the privacy laws for private-sector organizations. 

​

In addition, each province and territory has its own set of privacy legislation. In particular, the provinces of Alberta, British Columbia and Quebec have been deemed to have privacy laws substantially similar enough to PIPEDA that they are exempt from PIPEDA

 

For the purposes of research in Canada, it is important to be familiar with the privacy laws pertaining to Health Records, both federally (PIPEDA) and locally. Below are the relevant privacy laws for each province and territory:

​

Other Important Resources

​

  • The following documents are ethical guidelines for the protection of humans in clinical research. These documents began to emerge following the atrocities carried out in the name of research during World War II:

 

​The Nuremburg Code: Directives for Human Experimentation (1949)

 

​The Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects  (1964 first version adopted, 2013 current version)

 

The Belmont Report: â€‹Ethical Principles and Guidelines for the Protection of Human Subjects of Research (1979) 

​

ICH-GCP
Health Canada
Privacy Legislation
Ethical Docs
bottom of page